AngioDynamics (ANGO) Tops Q3 EPS by 4c, Reaffirms FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ANGO Hot Sheet
Price: $12.25 --0%
Financial Fact:
General and administrative: 8.17M
Today's EPS Names:
KTB, CABO, FDUS, More
Financial Fact:
General and administrative: 8.17M
Today's EPS Names:
KTB, CABO, FDUS, More
Join SI Premium – FREE
AngioDynamics (NASDAQ: ANGO) reported Q3 EPS of $0.03, $0.04 better than the analyst estimate of ($0.01). Revenue for the quarter came in at $74 million versus the consensus estimate of $76.32 million.
GUIDANCE:
AngioDynamics sees FY2022 EPS of ($0.02)-$0.02, versus the consensus of ($0.01). AngioDynamics sees FY2022 revenue of $310-315 million, versus the consensus of $313.7 million.
For earnings history and earnings-related data on AngioDynamics (ANGO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- Steris (STE) Tops Q3 EPS by 26c ; Offers Guidance
- Ship Finance (SFL) Tops Q3 EPS by 14c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
